Do we need all that emicizumab?

Lehtinen, Anna-Elina; Lassila, Riitta

Lehtinen, Anna-Elina; Lassila, Riitta.

Lehtinen AE; Helsinki University Hospital, Coagulation Disorders Unit, Department of Haematology, Comprehensive Cancer Centre, Helsinki, Finland.
Lassila R; Helsinki University Hospital, Coagulation Disorders Unit, Department of Haematology, Comprehensive Cancer Centre, Helsinki, Finland.

Haemophilia ; 28(2): e53-e55, 2022 Mar.

Article in English | MEDLINE | ID: covidwho-2232367

Subject(s)

Antibodies, Bispecific; Hemophilia A; Antibodies, Bispecific/pharmacology; Antibodies, Bispecific/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Factor VIII; Hemophilia A/drug therapy; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Limits: Humans Language: English Journal: Haemophilia Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: Hae.14483

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google